Accessibilité
Animation
Accessibilité

Poster

Combination of a glycomimetic antagonist to E-selectin and CXCR4, GMI-1359, with an anti-PD-L1 antibody attenuates regulatory T Cell infiltration and accelerates time to complete response in the murine CT26 tumor model

January 1, 2016

Published in: Society for Immuno Therapy of Cancer (SITC)